FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary
Status:
Not yet recruiting
Trial end date:
2024-02-22
Target enrollment:
Participant gender:
Summary
This is a prospective single arm cohort study designed to evaluate the diagnostic ability of
68Ga-FAPI-PET/CT scan in determining likely tissue of origin in Cancer of Unknown Primary
(CUP) patients not identified by standard of care. Patients with CUP will be either treatment
naïve or starting second-line treatment.